INFANT VACCINE  ~

Actively Seeking healthy infants (42 to 98 days old) to participate in a safety study of a new 20-valent pneumococcal vaccine.

 

DIABETES & CHRONIC KIDNEY DISEASE  ~

Actively seeking individuals, 18 years or older, to participate in a research study to look at how well Semaglutide works when compared to the ‘dummy medicine’ in slowing the growth and worsening of diabetic kidney disease in those with Type 2 Diabetes.

  COPD ~

Actively seeking men and women, between 40 and 80 years old, to test the safety and tolerability of study drug in patients with moderate-to-severe COPD with type 2 inflammation.

 

RSV VACCINE  ~

Actively Seeking non-pregnant women, ages 18 – 45 years of age, to help evaluate the safety and immunogenicity of an RSV vaccine.

RSV = Respiratory Syncytial Virus

Atopic Dermatitis  ~

Actively Seeking men and woman (ages 2+) with mild-to-moderate atopic dermatitis to evaluate the efficacy and safety of maintenance treatment and flare reduction with Crisaborole Ointment, 2%, once daily over 52 weeks

 Diabetes and Cardiovascular Disease ~

Actively seeking men and women (ages 40+) to test the effectiveness of 2 different study drugs on major cardiovascular events in patients who have Type II Diabetes.

 

URINARY STRESS INCONTINENCE (SUIs)

A new medical treatment for women who are pre-menopausal, 18-50 years of age, who experience stress incontinence.

 

STATIN INTOLERANCE  ~

To assess the effects of Bempedoic Acid on the occurrence of major cardiovascular events in patients with, or at high risk for, cardiovascular disease who are statin intolerant.

DIABETES & CVD  ~

Observing the effect of study medication on patients with Type II Diabetes and high cardiovascular disease or risks.

 

DIABETES  ~

Comparing the effectiveness and safety of an investigational once-weekly drug versus Semaglutide as an add-on therapy to metformin in patients with Type II Diabetes.

  Diabetes Add-On Therapy ~

An open-label trial comparing efficacy and safety of tirzepatide versus semaglutide
once weekly as add-on therapy to metformin in patients with Type II Diabetes.

Contact us at 519.659.4040 to find out more about participating in a study.

Why participate in a study?

Benefits to joining a clinical research study :

  • you may be able to help others by providing a better understanding of a medical condition and how it is treated in the future.
  • you may receive medications which are not available otherwise.
  • you may learn more about your medical condition.

Visit the joinastudy.ca website, to find out more about how clinical research studies work.